Northern Trust’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.4K | Sell |
135,909
-182,274
| -57% | -$75.7K | ﹤0.01% | 4210 |
|
|
2025
Q1 | $198K | Sell |
318,183
-24,883
| -7% | -$15.5K | ﹤0.01% | 3949 |
|
|
2024
Q4 | $573K | Buy |
343,066
+23,324
| +7% | +$39K | ﹤0.01% | 3610 |
|
|
2024
Q3 | $582K | Buy |
319,742
+75,191
| +31% | +$137K | ﹤0.01% | 3537 |
|
|
2024
Q2 | $1.47M | Sell |
244,551
-661
| -0.3% | -$3.99K | ﹤0.01% | 3069 |
|
|
2024
Q1 | $2.73M | Buy |
245,212
+1,372
| +0.6% | +$15.3K | ﹤0.01% | 2804 |
|
|
2023
Q4 | $3.63M | Buy |
243,840
+52,316
| +27% | +$779K | ﹤0.01% | 2681 |
|
|
2023
Q3 | $919K | Sell |
191,524
-1,178
| -0.6% | -$5.65K | ﹤0.01% | 3328 |
|
|
2023
Q2 | $1.45M | Sell |
192,702
-5,855
| -3% | -$44K | ﹤0.01% | 3196 |
|
|
2023
Q1 | $897K | Sell |
198,557
-4,374
| -2% | -$19.8K | ﹤0.01% | 3252 |
|
|
2022
Q4 | $2.29M | Sell |
202,931
-86,836
| -30% | -$979K | ﹤0.01% | 2932 |
|
|
2022
Q3 | $2.77M | Buy |
289,767
+89,781
| +45% | +$859K | ﹤0.01% | 2831 |
|
|
2022
Q2 | $1.62M | Buy |
199,986
+26,292
| +15% | +$213K | ﹤0.01% | 3170 |
|
|
2022
Q1 | $2.94M | Sell |
173,694
-111
| -0.1% | -$1.88K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $3.74M | Sell |
173,805
-859
| -0.5% | -$18.5K | ﹤0.01% | 2878 |
|
|
2021
Q3 | $12.9M | Buy |
174,664
+3,624
| +2% | +$268K | ﹤0.01% | 2097 |
|
|
2021
Q2 | $9.35M | Sell |
171,040
-5,010
| -3% | -$274K | ﹤0.01% | 2412 |
|
|
2021
Q1 | $13M | Buy |
176,050
+56,003
| +47% | +$4.13M | ﹤0.01% | 2124 |
|
|
2020
Q4 | $10.3M | Buy |
120,047
+4,231
| +4% | +$365K | ﹤0.01% | 2229 |
|
|
2020
Q3 | $4.37M | Buy |
+115,816
| New | +$4.37M | ﹤0.01% | 2629 |
|